Huons Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.98%

Huons Co. Ltd (243070) has an Asset Resilience Ratio of 1.98% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Huons Co. Ltd (243070) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩12.76 Billion

≈ $8.65 Million USD Cash + Short-term Investments

Total Assets

₩644.23 Billion

≈ $436.59 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Huons Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Huons Co. Ltd (243070) total assets.

Liquid Assets Composition Over Time

This chart breaks down Huons Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 243070 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩12.76 Billion	1.98%
Total Liquid Assets	₩12.76 Billion	1.98%

Asset Resilience Insights

Limited Liquidity: Huons Co. Ltd maintains only 1.98% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Huons Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Huons Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Huons Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Huons Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.36%	₩68.87 Billion ≈ $46.68 Million	₩606.29 Billion ≈ $410.87 Million	-3.59pp
2023-12-31	14.95%	₩80.33 Billion ≈ $54.44 Million	₩537.29 Billion ≈ $364.11 Million	-2.95pp
2022-12-31	17.90%	₩84.62 Billion ≈ $57.35 Million	₩472.63 Billion ≈ $320.29 Million	+1.85pp
2021-12-31	16.05%	₩70.13 Billion ≈ $47.52 Million	₩436.90 Billion ≈ $296.08 Million	-12.71pp
2020-12-31	28.76%	₩119.78 Billion ≈ $81.18 Million	₩416.50 Billion ≈ $282.26 Million	+11.95pp
2019-12-31	16.81%	₩50.49 Billion ≈ $34.21 Million	₩300.34 Billion ≈ $203.54 Million	+1.95pp
2018-12-31	14.86%	₩37.35 Billion ≈ $25.31 Million	₩251.37 Billion ≈ $170.35 Million	-7.05pp
2017-12-31	21.91%	₩47.33 Billion ≈ $32.07 Million	₩216.00 Billion ≈ $146.38 Million	+9.38pp
2016-12-31	12.53%	₩22.47 Billion ≈ $15.23 Million	₩179.34 Billion ≈ $121.54 Million	--

pp = percentage points

About Huons Co. Ltd

KQ:243070 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$158.32 Million

₩233.62 Billion KRW

Market Cap Rank

#17531 Global

#715 in Korea

Share Price

₩20050.00

Change (1 day)

-0.50%

52-Week Range

₩20000.00 - ₩38200.00

All Time High

₩66595.39